Literature DB >> 16434704

Virulence profile of strains of Cryptococcus neoformans var. grubii evaluated by experimental infection in BALB/c mice and correlation with exoenzyme activity.

Eriques Gonçalves da Silva1, Francisco de Assis Baroni2, Flavio César Viani1, Luciana da Silva Ruiz1, Rinaldo Ferreira Gandra3, Marcos Ereno Auler1, Amanda Latércia Tranches Dias1, Walderez Gambale1, Claudete Rodrigues Paula1.   

Abstract

To evaluate the virulence profile of strains of Cryptococcus neoformans var. grubii, 62 strains of this yeast were inoculated into BALB/c mice. It was found that 69 % of the strains were significantly more lethal to the mice and were recovered from a higher percentage (60 %) of the organs compared with the other 31 % of the strains, which were recovered from 35 % of organs tested. Those strains that provoked higher death rates were also recovered from the central nervous system at a higher rate (84 %) than the less lethal strains (32 %). This finding led to an investigation of the factors that enhanced the capacity for neurological infection and death of the animals. The results of this study suggested that environmental strains present different degrees of virulence. The correlation of exoenzyme production before and after inoculation and between the groups of mice indicated that exoenzyme production had no influence on differences in virulence among the strains studied.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16434704     DOI: 10.1099/jmm.0.46206-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  9 in total

1.  Voriconazole, combined with amphotericin B, in the treatment for pulmonary cryptococcosis caused by C. neoformans (serotype A) in mice with severe combined immunodeficiency (SCID).

Authors:  Eriques Gonçalves Silva; Claudete Rodrigues Paula; Francisco de Assis Baroni; Walderez Gambale
Journal:  Mycopathologia       Date:  2011-11-10       Impact factor: 2.574

2.  Combination efficacy of voriconazole and amphotericin B in the experimental disease in immunodeficient mice caused by fluconazole-resistant Cryptococcus neoformans.

Authors:  Eriques Gonçalves Silva; Claudete Rodrigues Paula; Amanda Latercia Tranches Dias; Marilene Rodrigues Chang; Luciana da Silva Ruiz; Valderez Gambale; Renato Araujo Prates; Martha Simões Ribeiro
Journal:  Mycopathologia       Date:  2010-10-24       Impact factor: 2.574

3.  Repression of Proteases and Hsp90 Chaperone Expression Induced by an Antiretroviral in Virulent Environmental Strains of Cryptococcus neoformans.

Authors:  Cleber Fernando Serafin; Ana Paula Paris; Claudete Rodrigues Paula; Rita Cássia Garcia Simão; Rinaldo Ferreira Gandra
Journal:  Microb Ecol       Date:  2016-12-02       Impact factor: 4.552

4.  Most environmental isolates of Cryptococcus neoformans var. grubii (serotype A) are not lethal for mice.

Authors:  Anastasia P Litvintseva; Thomas G Mitchell
Journal:  Infect Immun       Date:  2009-06-01       Impact factor: 3.441

5.  DNA mutations mediate microevolution between host-adapted forms of the pathogenic fungus Cryptococcus neoformans.

Authors:  Denise A Magditch; Tong-Bao Liu; Chaoyang Xue; Alexander Idnurm
Journal:  PLoS Pathog       Date:  2012-10-04       Impact factor: 6.823

6.  Genotypic analysis of clinical and environmental Cryptococcus neoformans isolates from Brazil reveals the presence of VNB isolates and a correlation with biological factors.

Authors:  Leonardo Euripedes Andrade-Silva; Kennio Ferreira-Paim; Thatiana Bragine Ferreira; Anderson Vilas-Boas; Delio José Mora; Verônica Morais Manzato; Fernanda Machado Fonseca; Kelli Buosi; Juliana Andrade-Silva; Bruno da Silva Prudente; Natalia Evelyn Araujo; Helioswilton Sales-Campos; Marcus Vinicius da Silva; Virmondes Rodrigues Júnior; Wieland Meyer; Mario Léon Silva-Vergara
Journal:  PLoS One       Date:  2018-03-05       Impact factor: 3.240

7.  Effect of virulence factors on the photodynamic inactivation of Cryptococcus neoformans.

Authors:  Renato A Prates; Beth Burgwyn Fuchs; Kazue Mizuno; Qurat Naqvi; Ilka T Kato; Martha S Ribeiro; Eleftherios Mylonakis; George P Tegos; Michael R Hamblin
Journal:  PLoS One       Date:  2013-01-18       Impact factor: 3.240

8.  Spinal cryptococcoma in an immunocompetent cat.

Authors:  S Belluco; J L Thibaud; J Guillot; M B Krockenberger; M Wyers; S Blot; M A Colle
Journal:  J Comp Pathol       Date:  2008-09-09       Impact factor: 1.311

Review 9.  The need for environmental surveillance to understand the ecology, epidemiology and impact of Cryptococcus infection in Africa.

Authors:  Hannah M Edwards; Massimo Cogliati; Geoffrey Kwenda; Matthew C Fisher
Journal:  FEMS Microbiol Ecol       Date:  2021-07-07       Impact factor: 4.519

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.